Navigation Links
Anti-allergy vaccine based on 'hygiene hypothesis'

A new vaccine has been developed that could obliterate common allergies like asthma, pollen and hayfever that afflict millions of people.//

The ‘hygiene hypothesis’ suggests that allergies may occur indirectly due to too much cleanliness as it deprives the immune system of a proper training against germs that have lived with humans for millions of years. As a result, the body begins to produce reactions against harmless substances like grass pollen.

This theory was exploited by a Swiss-based Cytos Biotechnology company to develop an anti-allergy drug that makes the immune system to focus on mycobacteria. This drug called CYT003 – QbG10 activates the immune system to attack potentially larger threats like mycobacteria, a group of bacteria found in soil and water that are come across rarely these days due to modern cleanliness. In this manner, the immune system is deceived and made to forget the allergens and look for bigger threats.

A study was conducted on 10 people with hay fever. It was found that there was a 100-fold reduction in the patient’s sensitivity to grass pollen after a 6-weeks course of injections.
A previous study reveals drug’s efficacy against house dust mite allergy. The patients were without any symptoms for one year when the drug was given along with doses of the allergen.
The researchers used a DNA strand that imitates mycobacteria’s genetic material. This DNA is packed into a fake virus particle and delivered into the body. This is taken up by the immune system.

The company is currently testing the drug in over 100 people with hay fever, house dust mite allergy, and allergic dermatitis. The results are expected to be out in the first half of 2007.

'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... January 23, 2017 , ... ... services for life science companies, has achieved ISO 17100:2015 certification following a ... ISO 17100 is the globally recognized standard that establishes guidance for critical ...
(Date:1/23/2017)... ... 2017 , ... The iaedp Foundation, recognized for its excellence ... treat the full spectrum of eating disorder problems, proudly announces the addition of ... the leading eating disorder treatments centers located throughout the U.S. As partners of ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... about the benefits of making new water infrastructure a number one priority. “As we ... we expect water infrastructure to become a top priority of our new political change ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Crystallization in Process Chemistry by Applying Simple PAT Tools . , Crystallization ... isolate and purify the desired product. Chemists now spend more time developing ...
(Date:1/23/2017)... ... ... is a set of camera tools that allow video editors to integrate up to two ... Christina Austin - CEO of Pixel Film Studios. , With ProRandom, video editors can ... ProRandom works by using a virtual camera to create the illusion of a shaky camera. ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... -- Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... Report Highlights: The report ... the investment opportunities Market forecasts till 2025, using estimated ... across the business segments, Regions and Countries Key developments ...
(Date:1/23/2017)... , Jan. 23, 2017  Using Astute ... at high risk for acute kidney injury (AKI) ... by globally-recognized care guidelines significantly improved ... severe AKI more than 33 percent, according to ... the journal Intensive Care Medicine. ...
(Date:1/23/2017)... 23, 2017 Ahead of today,s trading session, ... they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... relative laggards on Friday, January 20 th , 2017, down on ... reports on these stocks now at: ...
Breaking Medicine Technology: